Tumori 2015; 101(1): 1 - 1
Article Type: EDITORIAL
- • Accepted on 24/02/2015
- • Available online on 13/03/2015
- • Published in print on 20/03/2015
This article is available as full text PDF.
More than a century has passed since the first issue of
Whilst continuing to attract contributions from all over the world, the visibility of
2015 will see significant changes in the journal, starting from its title, to stress its nature of an international journal read by scientists and clinicians worldwide, with rapid online publication and Open Access capability upon request.
First of all,
Most importantly, we want
In addition, we want to stimulate and attract reports on large series of consecutive patients, that investigate the real impact of new techniques and treatments on day-to-day clinical practice. Our scope will be to implement the evidence from randomized clinical trials, with unselected evaluation of drugs and devices, and health technology assessments on the clinical, economic, and social consequences of cancer.
Last but not least, we welcome submissions of clinical trials protocols.
What we can promise to authors is a fair, rapid, and thorough peer-review process and, in case of acceptance, an ever increasing visibility of their contribution within the oncological community. To readers, we promise the publication of meaningful contributions that may improve basic and clinical oncology; to scientific societies, the affiliation to a 100+ years old journal, now fully equipped for 21st century, state-of-the-art publishing.
I welcome your comments, considerations, and suggestions and I look forward to meeting you as authors, reviewers, and readers of